1 Medical Stock You Shouldn't Touch With a 10-Foot Pole

Published on March 6, 2023

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a...

Continue reading on website
Other news

History Has Shown What Happens to Companies that Shy Away from New Tech, So Why Are So Many Afraid of Generative AI?

March 6, 2023
Many large companies are avoiding using Generative AI due to security concerns. This "wait and see" approach may lead to massive disruption by startups who do not share those concerns.

Valuation pressure on software startups is easing

March 6, 2023
Are you tired of bad news for startups? Bored of the layoffs, budget cuts and sermons from folks who suddenly discovered the efficiency gospel?Well, how about some good news? I have some for you: Software valuations staged a modest comeback this year.When we refer to startups, we generally mean tech-focused upstart companies. Sure, there are restaurant chain startups and, I suppose, ceramics start